Shifting the disease management paradigm from glucose: what are the pros?

Diabetes care

Volumn 32 Suppl 2, Issue , 2009, Pages

  Stirban, Alin ^a   Tschoepe, Diethelm ^a   Stratmann, Bernd ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLYCOSYLATED HEMOGLOBIN; LIPID;

ATHEROSCLEROSIS; BLOOD; BLOOD PRESSURE; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; THROMBOCYTE COUNT;

ATHEROSCLEROSIS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; OBESITY; PLATELET COUNT; PREVALENCE; RISK FACTORS;

MLCS; MLOWN;

EID: 75549088964     PISSN: None     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-s337     Document Type: Review

References (31)